Background: Knowledge gaps remain about how the Ryan White human immunodeficiency virus (HIV)/AIDS Program (RW) contributes to health outcomes. We examined the association between different RW service classes and retention in care (RiC) or viral suppression (VS). Methods: We identified Virginians engaged in any HIV care between 1 January and 31 December 2014. RW beneficiaries were classified by receipt of ≥1 service from 3 classes: Core medical, Support, and insurance and/or direct medication assistance through the AIDS Drug Assistance Program (ADAP). Receipt of all RW classes was defined as comprehensive assistance. We used multivariable logistic regression to compare the odds of RiC and of VS by comprehensive assistance and by RW classes alone and in combination. Results: Among 13104 individuals, 58% received any RW service and 17% comprehensive assistance. Comprehensive assistance is significantly associated with RiC (adjusted odds ratio [aOR], 8.8 [95% confidence interval {CI}, 7.2-10.8]) and viral suppression (aOR, 3.3 [95% CI, 2.9-3.8]). Receiving any 2 RW classes or Core alone is significantly associated with RiC and VS, with the strength of association decreasing as the number of classes decreases. Recipients of Support alone are significantly less likely to have VS (aOR, 0.75 [95% CI, .59-.96]). For ADAP recipients also receiving Core and/or Support, insurance assistance is significantly associated with VS compared to receiving direct medication only (aOR, 1.6 [95% CI, 1.3-1.9]); this relationship is not significant for those who receive ADAP alone. Conclusions: Receiving more classes of RW-funded services is associated with improved HIV outcomes. For some populations with insurance, RW-funded services may still be required for optimal health outcomes.
Background: Knowledge gaps remain about how the Ryan White human immunodeficiency virus (HIV)/AIDS Program (RW) contributes to health outcomes. We examined the association between different RW service classes and retention in care (RiC) or viral suppression (VS). Methods: We identified Virginians engaged in any HIV care between 1 January and 31 December 2014. RW beneficiaries were classified by receipt of ≥1 service from 3 classes: Core medical, Support, and insurance and/or direct medication assistance through the AIDS Drug Assistance Program (ADAP). Receipt of all RW classes was defined as comprehensive assistance. We used multivariable logistic regression to compare the odds of RiC and of VS by comprehensive assistance and by RW classes alone and in combination. Results: Among 13104 individuals, 58% received any RW service and 17% comprehensive assistance. Comprehensive assistance is significantly associated with RiC (adjusted odds ratio [aOR], 8.8 [95% confidence interval {CI}, 7.2-10.8]) and viral suppression (aOR, 3.3 [95% CI, 2.9-3.8]). Receiving any 2 RW classes or Core alone is significantly associated with RiC and VS, with the strength of association decreasing as the number of classes decreases. Recipients of Support alone are significantly less likely to have VS (aOR, 0.75 [95% CI, .59-.96]). For ADAP recipients also receiving Core and/or Support, insurance assistance is significantly associated with VS compared to receiving direct medication only (aOR, 1.6 [95% CI, 1.3-1.9]); this relationship is not significant for those who receive ADAP alone. Conclusions: Receiving more classes of RW-funded services is associated with improved HIV outcomes. For some populations with insurance, RW-funded services may still be required for optimal health outcomes.
Authors: Arleen A Leibowitz; Robbie Lester; Philip G Curtis; Kevin Farrell; Aaron Fox; Luke H Klipp; Jason Wise Journal: J Acquir Immune Defic Syndr Date: 2013-11-01 Impact factor: 3.731
Authors: Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman Journal: Clin Infect Dis Date: 2011-03-15 Impact factor: 9.079
Authors: Stephen A Berry; John A Fleishman; Baligh R Yehia; Laura W Cheever; Heather Hauck; P Todd Korthuis; W Christopher Mathews; Jeanne Keruly; Ank E Nijhawan; Allison L Agwu; Charurut Somboonwit; Richard D Moore; Kelly A Gebo Journal: Clin Infect Dis Date: 2016-05-03 Impact factor: 9.079
Authors: Mary K Irvine; Stephanie A Chamberlin; Rebekkah S Robbins; Julie E Myers; Sarah L Braunstein; Beau J Mitts; Graham A Harriman; Fabienne Laraque; Denis Nash Journal: Clin Infect Dis Date: 2014-10-09 Impact factor: 9.079
Authors: David A Wohl; Rita K Kuwahara; Kamran Javadi; Christine Kirby; David L Rosen; Sonia Napravnik; Claire Farel Journal: AIDS Patient Care STDS Date: 2017-10-17 Impact factor: 5.078
Authors: Emma Sophia Kay; Andrew Edmonds; Christina Ludema; Adaora Adimora; Maria L Alcaide; Aruna Chandran; Mardge H Cohen; Mallory O Johnson; Seble Kassaye; Mirjam-Colette Kempf; Caitlin A Moran; Oluwakemi Sosanya; Tracey E Wilson Journal: AIDS Care Date: 2020-11-25
Authors: Yaoyu Zhong; Christopher M Beattie; John Rojas; X Pamela Farquhar; Paul A Brown; Ellen W Wiewel Journal: Am J Public Health Date: 2020-05-21 Impact factor: 11.561
Authors: Steven P Masiano; Erika G Martin; Rose S Bono; Bassam Dahman; Lindsay M Sabik; Faye Z Belgrave; Adaora A Adimora; April D Kimmel Journal: J Int AIDS Soc Date: 2019-05 Impact factor: 5.396
Authors: J E Sherbuk; K A McManus; E T Rogawski McQuade; T Knick; Z Henry; R Dillingham Journal: Open Forum Infect Dis Date: 2018-09-20 Impact factor: 3.835